-The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid.
about
Diagnosis of prostate cancer via nanotechnological approachAn extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors.Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies.Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation.Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
P2860
-The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
-The advancement of biomarker- ...... ine as an analytical biofluid.
@ast
-The advancement of biomarker- ...... ine as an analytical biofluid.
@en
type
label
-The advancement of biomarker- ...... ine as an analytical biofluid.
@ast
-The advancement of biomarker- ...... ine as an analytical biofluid.
@en
prefLabel
-The advancement of biomarker- ...... ine as an analytical biofluid.
@ast
-The advancement of biomarker- ...... ine as an analytical biofluid.
@en
P2860
P356
P1476
-The advancement of biomarker- ...... ine as an analytical biofluid.
@en
P2093
Anna E Lokshin
Brian M Nolen
P2860
P304
P356
10.5301/JBM.2011.8613
P577
2011-09-21T00:00:00Z